Notably, CCL5 (chemokine ligand 5), whose expression is associated with recruitment of NK cells and dendritic cells in the tumor microenvironment [15, 16], was robustly up-regulated upon treatment with UMCD6 (**p < 0.01). This evidence concerns the gene CCL5 and neoplasm.